Mistake 7: Not rotating injection sites Using the same spot repeatedly causes lipohypertrophy, which means hardened fatty lumps under the skin
Dose tracking is the floor of any GLP-1 tracker because the medication is a recurring weekly action, not a daily one, and people are bad at remembering recurring weekly actions
Eloralintide is a selective amylin receptor agonist
#Nephrology #Dialysis #Semaglutide #GLP1 #Diabetes #Cardiovascular #EASD2025 #PatientSafety #MedicalResearch To view or add a comment, sign in How to individualize renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERA Nephrology Dialysis Transplantation, Volume 40, Issue 10, October 2025, Pages 19771988, Published: 13 May 2025 The interrelated pandemics of obesity and type 2 diabetes mellitus (T2DM) are fuelling an increase in the prevalence of chronic kidney disease (CKD), which amplifies the risk of cardiovascular events and may progress to end-stage kidney disease (ESKD)
But in rare cases, constipation can signal a more serious problem that requires medical attention
Wipe the stopper before each needle entry, not only the first time
